Read tips, insights, and stories.
NAD+ is at the forefront of longevity and cellular energy research. Explore what it is, how it's studied, and why it matters.
NAD+ (nicotinamide adenine dinucleotide) is at the center of one of the most active areas in longevity research today. It's not a peptide in the strict sense — it's a coenzyme — but it's widely grouped with research peptides because of how it's used and studied.
NAD+ is a coenzyme present in every living cell, involved in:
NAD+ levels naturally decline with age, which has driven enormous interest in supplementation research.
The published literature on NAD+ has expanded rapidly in the last decade. Key research areas include:
Declining NAD+ is one of the most consistently-documented biomarkers of cellular aging. Whether restoration reverses aging outcomes is the central question driving current research.
NAD+ is typically administered via subcutaneous injection in research protocols. Because of its relatively short half-life, dosing frequency and concentration both matter substantially.
Researchers also study NAD+ precursors like NMN and NR, which the body converts into NAD+. Each has different bioavailability and kinetic profiles — another layer to consider in research design.
NAD+ research sits at the intersection of mitochondrial biology, longevity science, and clinical medicine. The field is still early, the questions are large, and the compound demands high-purity, well-documented sourcing.
